Description
Developer of a drug infusion system for the people suffering from cancer. The company develops and markets an endovascular device which provides direct drug delivery to tumors and other delivery applications.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-May-2016 | 00.000 | Completed | Out of Business | ||
2. Angel (individual) | 17-Dec-2010 | 00000 | 00.000 | Completed | Generating Revenue | |
1. Angel (individual) | 11-Jan-2008 | $1.68M | $1.68M | Completed | Generating Revenue |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2711739-A1 | Multi-function catheter and use thereof | Abandoned | 09-Jan-2008 | 00000000000 | |
JP-2011509158-A | Multi-function catheter and use thereof | Pending | 09-Jan-2008 | 00000000000 | 0 |
EP-2240231-A1 | Multi-function catheter and use thereof | Withdrawn | 09-Jan-2008 | 00000000000 | 0 |
EP-2240231-A4 | Multi-function catheter and use thereof | Withdrawn | 09-Jan-2008 | 00000000000 | 0 |
US-20050267407-A1 | Multi-function catheter and use thereof | Abandoned | 01-Feb-2002 | A61M25/1011 | 00 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Robert Goldman | Co-Founder, President, Chief Technology Officer, Chief Executive Officer & Chairman |
Name | Representing | Role | Since |
---|---|---|---|
Joe Maemone | IsoFlow | Board Member | 000 0000 |
Robert Goldman | Self | Co-Founder, President, Chief Technology Officer, Chief Executive Officer & Chairman | 000 0000 |